ACT: Analyzing the Composition of Tears to Identify Cancer (Breast, Ovarian, Colon)
Specifically, this study will compare the protein profile in tear fluid from patients with
breast, ovarian or colon cancer versus "normal male and female patients" for differences
that show promise as a diagnostic indicator. If such differences can be found, then their
diagnostic potential will be assessed and developed further in a subsequent study. The
long-term goal of this project will be to develop a screening tool for the detection of
breast and/or other cancers.
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
This study will further evaluate the use of tumor markers (substances in body fluids that may be elevated as a consequence of certain diseases or conditions) in the diagnosis of breast and/or other cancers.
Collection of specimen and analysis with SELDI-MS
V. Suzanne Klimberg, MD
University of Arkansas
United States: Food and Drug Administration
|University of Arkansas for Medical Sciences||Little Rock, Arkansas 72205|